Clinical trials
Retinitis Pigmentosa trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
36 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2009 | 1 |
| 2012 | 2 |
| 2013 | 1 |
| 2014 | 3 |
| 2015 | 5 |
| 2016 | 1 |
| 2018 | 7 |
| 2019 | 4 |
| 2020 | 2 |
| 2021 | 3 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 36 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts | 6 |
| University Hospital, Strasbourg, France | 2 |
| Aier School of Ophthalmology, Central South University | 1 |
| Barcelona Macula Foundation | 1 |
| Beirut Eye Specialist Hospital | 1 |
| Chaitanya Hospital, Pune | 1 |
| Eyecure Therapeutics Inc. | 1 |
| Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 1 |
| Hadassah Medical Organization | 1 |
| Hillel Yaffe Medical Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Retinitis Pigmentosa | 36 |
| Macular Degeneration | 5 |
| Retinal Degeneration | 5 |
| Stargardt Disease | 4 |
| Cone-Rod Dystrophies | 3 |
| Glaucoma | 3 |
| Macular Edema | 3 |
| Retinal Dystrophies | 3 |
| Choroideremia | 2 |
| Cone Dystrophy | 2 |
Trials
Showing 51 to 36 of 36. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.